{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:19:59Z","timestamp":1793996399432,"version":"4.8.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-88939-9","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T11:49:30Z","timestamp":1741607370000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of sarcopenia in young patients with inflammatory arthritis: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-9977","authenticated-orcid":false,"given":"Myroslava","family":"Kulyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dzhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"88939_CR1","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European working group on sarcopenia in older people. Age Ageing 39, 412\u2013423. https:\/\/doi.org\/10.1093\/ageing\/afq034 (2010).","journal-title":"Age Ageing"},{"key":"88939_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48, 16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169 (2019).","journal-title":"Age Ageing"},{"key":"88939_CR3","doi-asserted-by":"publisher","first-page":"afae052","DOI":"10.1093\/ageing\/afae052","volume":"53","author":"B Kirk","year":"2024","unstructured":"Kirk, B. et al. The conceptual definition of sarcopenia: Delphi consensus from the global leadership initiative in sarcopenia (GLIS). Age Ageing 53, afae052. https:\/\/doi.org\/10.1093\/ageing\/afae052 (2024).","journal-title":"Age Ageing"},{"key":"88939_CR4","doi-asserted-by":"publisher","first-page":"e0169548","DOI":"10.1371\/journal.pone.0169548","volume":"12","author":"C Beaudart","year":"2017","unstructured":"Beaudart, C., Zaaria, M., Pasleau, F., Reginster, J. Y. & Bruyere, O. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One 12, e0169548. https:\/\/doi.org\/10.1371\/journal.pone.0169548 (2017).","journal-title":"PLoS One"},{"key":"88939_CR5","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.3390\/ijerph17124273","volume":"17","author":"L Zaccagni","year":"2020","unstructured":"Zaccagni, L. et al. Handgrip strength in young adults: association with anthropometric variables and laterality. Int. J. Environ. Res. Public Health 17, 4273. https:\/\/doi.org\/10.3390\/ijerph17124273 (2020).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"88939_CR6","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ageing\/afw071","volume":"45","author":"SL De Buyser","year":"2016","unstructured":"De Buyser, S. L. et al. Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing 45, 602\u2013608. https:\/\/doi.org\/10.1093\/ageing\/afw071 (2016).","journal-title":"Age Ageing"},{"key":"88939_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcsm.12160","volume":"8","author":"L Dos Santos","year":"2017","unstructured":"Dos Santos, L., Cyrino, E. S., Antunes, M., Santos, D. A. & Sardinha, L. B. Sarcopenia and physical independence in older adults: the independent and synergic role of muscle mass and muscle function. J. Cachexia Sarcopenia Muscle 8, 245\u2013250. https:\/\/doi.org\/10.1002\/jcsm.12160 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR8","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/gerona\/glx245","volume":"73","author":"LA Schaap","year":"2018","unstructured":"Schaap, L. A., van Schoor, N. M., Lips, P. & Visser, M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: The longitudinal aging study amsterdam. J. Gerontol. A Biol. Sci. Med. Sci 73, 1199\u20131204. https:\/\/doi.org\/10.1093\/gerona\/glx245 (2018).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci"},{"key":"88939_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.eurger.2015.12.012","volume":"7","author":"G Bahat","year":"2016","unstructured":"Bahat, G. & Lhan, B. Sarcopenia and the cardiometabolic syndrome: A narrative review. Eur. Geriatr. Med. 7, 220\u2013223. https:\/\/doi.org\/10.1016\/j.eurger.2015.12.012 (2016).","journal-title":"Eur. Geriatr. Med."},{"key":"88939_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1479972316679664","volume":"14","author":"AE Bone","year":"2017","unstructured":"Bone, A. E., Hepgul, N., Kon, S. & Maddocks, M. Sarcopenia and frailty in chronic respiratory disease. Chron. Respir. Dis. 14, 85\u201399. https:\/\/doi.org\/10.1177\/1479972316679664 (2017).","journal-title":"Chron. Respir. Dis."},{"issue":"1164","key":"88939_CR11","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jamda.2016.09.013","volume":"17","author":"KV Chang","year":"2016","unstructured":"Chang, K. V., Hsu, T. H., Wu, W. T., Huang, K. C. & Han, D. S. Association between sarcopenia and cognitive impairment: a systematic review and meta-analysis. J. Am. Med. Dir. Assoc. 17 (1164), e7-1164.e15. https:\/\/doi.org\/10.1016\/j.jamda.2016.09.013 (2016).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"88939_CR12","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.3390\/ijms21165678","volume":"21","author":"HJ An","year":"2020","unstructured":"An, H. J. et al. Sarcopenia in autoimmune and rheumatic diseases: a comprehensive review. Int. J. Mol. Sci. 21, 5678. https:\/\/doi.org\/10.3390\/ijms21165678 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"88939_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/1756-185X.14856","volume":"26","author":"H Hanaoka","year":"2023","unstructured":"Hanaoka, H. et al. Sarcopenia in patients with rheumatic musculoskeletal diseases. Int. J. Rheum. Dis. 26, 2007\u20132013. https:\/\/doi.org\/10.1111\/1756-185X.14856 (2023).","journal-title":"Int. J. Rheum. Dis."},{"key":"88939_CR14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3390\/jcm7120504","volume":"7","author":"M Barone","year":"2018","unstructured":"Barone, M. et al. Sarcopenia in patients with rheumatic diseases: prevalence and associated risk factors. J. Clin. Med. 7, 504. https:\/\/doi.org\/10.3390\/jcm7120504 (2018).","journal-title":"J. Clin. Med."},{"key":"88939_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41584-023-00921-9","volume":"19","author":"JL Bennett","year":"2023","unstructured":"Bennett, J. L., Pratt, A. G., Dodds, R., Sayer, A. A. & Isaacs, J. D. Rheumatoid sarcopenia: loss of skeletal muscle strength and mass in rheumatoid arthritis. Nat. Rev. Rheumatol. 19, 239\u2013251. https:\/\/doi.org\/10.1038\/s41584-023-00921-9 (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"88939_CR16","doi-asserted-by":"publisher","first-page":"e002600","DOI":"10.1136\/rmdopen-2022-002600","volume":"8","author":"R Dietzel","year":"2022","unstructured":"Dietzel, R. et al. Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition. RMD Open 8, e002600. https:\/\/doi.org\/10.1136\/rmdopen-2022-002600 (2022).","journal-title":"RMD Open"},{"key":"88939_CR17","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.3390\/cells11152359","volume":"11","author":"GE Jimenez-Gutierrez","year":"2022","unstructured":"Jimenez-Gutierrez, G. E. et al. Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update. Cells 11, 2359. https:\/\/doi.org\/10.3390\/cells11152359 (2022).","journal-title":"Cells"},{"key":"88939_CR18","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","volume":"22","author":"DI Jang","year":"2021","unstructured":"Jang, D. I. et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int. J. Mol. Sci. 22, 2719. https:\/\/doi.org\/10.3390\/ijms22052719 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"88939_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2019.03.027","volume":"50","author":"M Murakami","year":"2019","unstructured":"Murakami, M., Kamimura, D. & Hirano, T. Pleiotropy and specificity: insights from the interleukin 6 family of cytokines. Immunity 50, 812\u2013831. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.027 (2019).","journal-title":"Immunity"},{"key":"88939_CR20","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","volume":"1088","author":"A Thoma","year":"2018","unstructured":"Thoma, A. & Lightfoot, A. P. NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy. Adv. Exp. Med. Biol. 1088, 267\u2013279. https:\/\/doi.org\/10.1007\/978-981-13-1435-3_12 (2018).","journal-title":"Adv. Exp. Med. Biol."},{"key":"88939_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/bs.acc.2021.09.006","volume":"106","author":"P Esposito","year":"2022","unstructured":"Esposito, P. et al. Myostatin: Basic biology to clinical application. Adv. Clin. Chem. 106, 181\u2013234. https:\/\/doi.org\/10.1016\/bs.acc.2021.09.006 (2022).","journal-title":"Adv. Clin. Chem."},{"key":"88939_CR22","doi-asserted-by":"publisher","first-page":"e0229638","DOI":"10.1371\/journal.pone.0229638","volume":"15","author":"RA Armstrong","year":"2020","unstructured":"Armstrong, R. A. et al. Low serum 25-hydroxyvitamin D status in the pathogenesis of stress fractures in military personnel: An evidenced link to support injury risk management. PLoS One 15, e0229638. https:\/\/doi.org\/10.1371\/journal.pone.0229638 (2020).","journal-title":"PLoS One"},{"key":"88939_CR23","doi-asserted-by":"publisher","first-page":"e3679","DOI":"10.1210\/clinem\/dgac388","volume":"107","author":"M Garrahan","year":"2022","unstructured":"Garrahan, M. et al. Serum 25-hydroxyvitamin D is associated with bone microarchitecture and strength in a multiracial cohort of young adults. J. Clin. Endocrinol. Metab. 107, e3679\u2013e3688. https:\/\/doi.org\/10.1210\/clinem\/dgac388 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"88939_CR24","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bonr.2018.04.004","volume":"8","author":"JE Gunton","year":"2018","unstructured":"Gunton, J. E. & Girgis, C. M. Vitamin D and muscle. Bone Rep. 8, 163\u2013167. https:\/\/doi.org\/10.1016\/j.bonr.2018.04.004 (2018).","journal-title":"Bone Rep."},{"key":"88939_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00223-015-0054-x","volume":"97","author":"CM Girgis","year":"2015","unstructured":"Girgis, C. M. et al. Vitamin D receptor ablation and vitamin D deficiency result in reduced grip strength, altered muscle fibers, and increased myostatin in mice. Calcif. Tissue Int. 97, 602\u2013610. https:\/\/doi.org\/10.1007\/s00223-015-0054-x (2015).","journal-title":"Calcif. Tissue Int."},{"key":"88939_CR26","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/jcsm.12460","volume":"10","author":"CM Girgis","year":"2019","unstructured":"Girgis, C. M. et al. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. J. Cachexia Sarcopenia Muscle 10, 1228\u20131240. https:\/\/doi.org\/10.1002\/jcsm.12460 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR27","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/art.23719","volume":"59","author":"JT Giles","year":"2008","unstructured":"Giles, J. T. et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthr. Rheum. 59, 807\u2013815. https:\/\/doi.org\/10.1002\/art.23719 (2008).","journal-title":"Arthr. Rheum."},{"key":"88939_CR28","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/rheumatology\/ker004","volume":"50","author":"HH Dao","year":"2011","unstructured":"Dao, H. H., Do, Q. T. & Sakamoto, J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford) 50, 1250\u20131258. https:\/\/doi.org\/10.1093\/rheumatology\/ker004 (2011).","journal-title":"Rheumatology (Oxford)"},{"key":"88939_CR29","first-page":"322","volume":"39","author":"R Aguiar","year":"2014","unstructured":"Aguiar, R., Sequeira, J., Meirinhos, T., Ambrosio, C. & Barcelos, A. SARCOSPA\u2014Sarcopenia in spondyloarthritis patients. Acta Reumatol. Port. 39, 322\u2013326 (2014).","journal-title":"Acta Reumatol. Port."},{"key":"88939_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5152\/eurjrheum.2015.0038","volume":"2","author":"SC Dogan","year":"2015","unstructured":"Dogan, S. C. et al. Sarcopenia in women with rheumatoid arthritis. Eur. J. Rheumatol. 2, 57\u201361. https:\/\/doi.org\/10.5152\/eurjrheum.2015.0038 (2015).","journal-title":"Eur. J. Rheumatol."},{"key":"88939_CR31","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00394-009-0017-y","volume":"48","author":"AC Elkan","year":"2009","unstructured":"Elkan, A. C., Engvall, I. L., Cederholm, T. & Hafstrom, I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: feasibility of anthropometry, mini nutritional assessment and body composition techniques. Eur. J. Nutr. 48, 315\u2013322. https:\/\/doi.org\/10.1007\/s00394-009-0017-y (2009).","journal-title":"Eur. J. Nutr."},{"key":"88939_CR32","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00296-017-3665-x","volume":"37","author":"A Ngeuleu","year":"2017","unstructured":"Ngeuleu, A. et al. Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors. Rheumatol. Int. 37, 1015\u20131020. https:\/\/doi.org\/10.1007\/s00296-017-3665-x (2017).","journal-title":"Rheumatol. Int."},{"key":"88939_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jcsm.12189","volume":"8","author":"A Tournadre","year":"2017","unstructured":"Tournadre, A. et al. Changes in body composition and metabolic profile during interleukin 6 inhibition in rheumatoid arthritis. J. Cachexia Sarcopenia Muscle 8, 639\u2013646. https:\/\/doi.org\/10.1002\/jcsm.12189 (2017).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12891-016-1155-z","volume":"17","author":"A El Maghraoui","year":"2016","unstructured":"El Maghraoui, A. et al. Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?. BMC Musculoskelet. Disord. 17, 268. https:\/\/doi.org\/10.1186\/s12891-016-1155-z (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"88939_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.5114\/reum.2017.71627","volume":"55","author":"M Krajewska-Wlodarczyk","year":"2017","unstructured":"Krajewska-Wlodarczyk, M., Owczarczyk-Saczonek, A. & Placek, W. Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis. Reumatologia 55, 215\u2013221. https:\/\/doi.org\/10.5114\/reum.2017.71627 (2017).","journal-title":"Reumatologia"},{"key":"88939_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/14397595.2018.1510565","volume":"29","author":"M Torii","year":"2019","unstructured":"Torii, M. et al. Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis. Mod. Rheumatol. 29, 589\u2013595. https:\/\/doi.org\/10.1080\/14397595.2018.1510565 (2019).","journal-title":"Mod. Rheumatol."},{"key":"88939_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.22141\/pjs.13.2.2023.372","volume":"13","author":"M Kulyk","year":"2023","unstructured":"Kulyk, M. & Dzhus, M. Handgrip strength, physical activity, and body composition in young adults with juvenile idiopathic arthritis. Pain Joints Spine 13, 101\u2013107. https:\/\/doi.org\/10.22141\/pjs.13.2.2023.372 (2023).","journal-title":"Pain Joints Spine"},{"key":"88939_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.pedhc.2018.02.005","volume":"32","author":"JL Jacobson","year":"2018","unstructured":"Jacobson, J. L. & Pham, J. T. Juvenile idiopathic arthritis: a focus on pharmacologic management. J. Pediatr. Health Care 32, 515\u2013528. https:\/\/doi.org\/10.1016\/j.pedhc.2018.02.005 (2018).","journal-title":"J. Pediatr. Health Care"},{"key":"88939_CR39","doi-asserted-by":"publisher","first-page":"E201715","DOI":"10.21802\/acm.2017.1.5","volume":"23","author":"M Dzhus","year":"2017","unstructured":"Dzhus, M. Juvenile idiopathic arthritis in adults: long-term observation of ukrainian patients. Arch. Clin. Med. 23, E201715. https:\/\/doi.org\/10.21802\/acm.2017.1.5 (2017).","journal-title":"Arch. Clin. Med."},{"key":"88939_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.32345\/2664-4738.1-2.2017.02","volume":"13","author":"M Dzhus","year":"2017","unstructured":"Dzhus, M., Mostbauer, H., Karasevska, T. & Ivashkivsky, O. Clinical course of juvenile idiopathic arthritis in HLA-B27-positive patients in adulthood. Med. Sci. Ukr. 13, 12\u201320. https:\/\/doi.org\/10.32345\/2664-4738.1-2.2017.02 (2017).","journal-title":"Med. Sci. Ukr."},{"key":"88939_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s42358-024-00378-8","volume":"64","author":"SHS Lancas","year":"2024","unstructured":"Lancas, S. H. S., Furlan, M. Z. B., Fernandes, T. A. P., Drumond, S. G. L. & Magalhaes, C. S. Presentation of enthesitis-related arthritis and juvenile-onset spondyloarthritis: a cross-sectional study in a pediatric and adult clinic. Adv. Rheumatol. 64, 39. https:\/\/doi.org\/10.1186\/s42358-024-00378-8 (2024).","journal-title":"Adv. Rheumatol."},{"key":"88939_CR42","doi-asserted-by":"publisher","first-page":"101984","DOI":"10.1016\/j.berh.2024.101984","volume":"38","author":"F Oliveira Ramos","year":"2024","unstructured":"Oliveira Ramos, F., Zinterl, C. & Fonseca, J. E. A lifelong journey: Long-term perspectives on juvenile idiopathic arthritis. Best Pract. Res. Clin. Rheumatol. 38, 101984. https:\/\/doi.org\/10.1016\/j.berh.2024.101984 (2024).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"88939_CR43","first-page":"2509","volume":"69","author":"G Fitzgerald","year":"2017","unstructured":"Fitzgerald, G. & O\u2019Shea, F. High prevalence of sarcopenia in axial spondyloarthropathy cohort. Arthr. Rheumatol. 69, 2509 (2017).","journal-title":"Arthr. Rheumatol."},{"key":"88939_CR44","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00223-023-01074-3","volume":"112","author":"B Merle","year":"2023","unstructured":"Merle, B., Cottard, M., Sornay-Rendu, E., Szulc, P. & Chapurlat, R. Spondyloarthritis and sarcopenia: prevalence of probable sarcopenia and its impact on disease burden: the saspar study. Calcif. Tissue Int. 112, 647\u2013655. https:\/\/doi.org\/10.1007\/s00223-023-01074-3 (2023).","journal-title":"Calcif. Tissue Int."},{"key":"88939_CR45","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1007\/s10067-023-06770-x","volume":"42","author":"N Kanjanavaikoon","year":"2023","unstructured":"Kanjanavaikoon, N., Saisirivechakun, P. & Chaiamnuay, S. Age, body mass index, and function as the independent predictors of sarcopenia in axial spondyloarthritis: a cross-sectional analysis. Clin. Rheumatol. 42, 3257\u20133265. https:\/\/doi.org\/10.1007\/s10067-023-06770-x (2023).","journal-title":"Clin. Rheumatol."},{"key":"88939_CR46","first-page":"470","volume":"29","author":"MJ Santos","year":"2011","unstructured":"Santos, M. J., Vinagre, F., Canas da Silva, J., Gil, V. & Fonseca, J. E. Body composition phenotypes in systemic lupus erythematosus and rheumatoid arthritis: a comparative study of Caucasian female patients. Clin. Exp. Rheumatol. 29, 470\u2013476 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"88939_CR47","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jcsm.12381","volume":"10","author":"JZ Lin","year":"2019","unstructured":"Lin, J. Z. et al. Myopenia is associated with joint damage in rheumatoid arthritis: a cross-sectional study. J. Cachexia Sarcopenia Muscle 10, 355\u2013367. https:\/\/doi.org\/10.1002\/jcsm.12381 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR48","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1111\/1756-185X.13335","volume":"21","author":"M Tada","year":"2018","unstructured":"Tada, M., Yamada, Y., Mandai, K. & Hidaka, N. Matrix metalloprotease 3 is associated with sarcopenia in rheumatoid arthritis\u2014Results from the CHIKARA study. Int. J. Rheum. Dis. 21, 1962\u20131969. https:\/\/doi.org\/10.1111\/1756-185X.13335 (2018).","journal-title":"Int. J. Rheum. Dis."},{"key":"88939_CR49","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/ggi.13747","volume":"19","author":"T Mochizuki","year":"2019","unstructured":"Mochizuki, T., Yano, K., Ikari, K. & Okazaki, K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: A cross-sectional study. Geriatr. Gerontol. Int. 19, 907\u2013912. https:\/\/doi.org\/10.1111\/ggi.13747 (2019).","journal-title":"Geriatr. Gerontol. Int."},{"key":"88939_CR50","doi-asserted-by":"publisher","first-page":"e0217462","DOI":"10.1371\/journal.pone.0217462","volume":"14","author":"L Vlietstra","year":"2019","unstructured":"Vlietstra, L. et al. Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity. PLoS One 14, e0217462. https:\/\/doi.org\/10.1371\/journal.pone.0217462 (2019).","journal-title":"PLoS One"},{"key":"88939_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/s12877-023-04085-9","volume":"23","author":"T Huang","year":"2023","unstructured":"Huang, T. et al. Prevalence and risk factors of osteosarcopenia: a systematic review and meta-analysis. BMC Geriatr. 23, 369. https:\/\/doi.org\/10.1186\/s12877-023-04085-9 (2023).","journal-title":"BMC Geriatr."},{"key":"88939_CR52","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-018-4570-1","volume":"29","author":"T Bettis","year":"2018","unstructured":"Bettis, T., Kim, B. J. & Hamrick, M. W. Impact of muscle atrophy on bone metabolism and bone strength: implications for muscle-bone crosstalk with aging and disuse. Osteoporos Int. 29, 1713\u20131720. https:\/\/doi.org\/10.1007\/s00198-018-4570-1 (2018).","journal-title":"Osteoporos Int."},{"key":"88939_CR53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00198-012-2057-z","volume":"24","author":"S Verschueren","year":"2013","unstructured":"Verschueren, S. et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos. Int. 24, 87\u201398. https:\/\/doi.org\/10.1007\/s00198-012-2057-z (2013).","journal-title":"Osteoporos. Int."},{"key":"88939_CR54","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jbmr.4293","volume":"36","author":"NC Harvey","year":"2021","unstructured":"Harvey, N. C. et al. Sarcopenia definitions as predictors of fracture risk independent of FRAX\u00ae, falls, and BMD in the osteoporotic fractures in men (MrOS) study: a meta-analysis. J. Bone Miner. Res. 36, 1235\u20131244. https:\/\/doi.org\/10.1002\/jbmr.4293 (2021).","journal-title":"J. Bone Miner. Res."},{"key":"88939_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10067-023-06779-2","volume":"43","author":"M Nakayama","year":"2024","unstructured":"Nakayama, M. et al. Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study. Clin. Rheumatol. 43, 521\u2013526. https:\/\/doi.org\/10.1007\/s10067-023-06779-2 (2024).","journal-title":"Clin. Rheumatol."},{"key":"88939_CR56","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.arr.2010.05.005","volume":"9","author":"KG Beenakker","year":"2010","unstructured":"Beenakker, K. G. et al. Patterns of muscle strength loss with age in the general population and patients with a chronic inflammatory state. Ageing Res. Rev. 9, 431\u2013436. https:\/\/doi.org\/10.1016\/j.arr.2010.05.005 (2010).","journal-title":"Ageing Res. Rev."},{"key":"88939_CR57","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/medicina55110730","volume":"55","author":"R Muller","year":"2019","unstructured":"Muller, R. et al. Factors associated with low lean mass in early rheumatoid arthritis: a cross-sectional study. Medicina (Kaunas) 55, 730. https:\/\/doi.org\/10.3390\/medicina55110730 (2019).","journal-title":"Medicina (Kaunas)"},{"key":"88939_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5606\/ArchRheumatol.2017.6078","volume":"32","author":"M Alkan Melikoglu","year":"2017","unstructured":"Alkan Melikoglu, M. Presarcopenia and its impact on disability in female patients with rheumatoid arthritis. Arch. Rheumatol. 32, 53\u201359. https:\/\/doi.org\/10.5606\/ArchRheumatol.2017.6078 (2017).","journal-title":"Arch. Rheumatol."},{"key":"88939_CR59","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/ard.56.5.326","volume":"56","author":"R Munro","year":"1997","unstructured":"Munro, R. & Capell, H. Prevalence of low body mass in rheumatoid arthritis: association with the acute phase response. Ann. Rheum. Dis. 56, 326\u2013329. https:\/\/doi.org\/10.1136\/ard.56.5.326 (1997).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR60","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13075-019-1962-3","volume":"21","author":"CG Fenton","year":"2019","unstructured":"Fenton, C. G. et al. Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis. Arthr. Res. Ther. 21, 182. https:\/\/doi.org\/10.1186\/s13075-019-1962-3 (2019).","journal-title":"Arthr. Res. Ther."},{"key":"88939_CR61","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s10067-020-04929-4","volume":"39","author":"Y Yamada","year":"2020","unstructured":"Yamada, Y. et al. Glucocorticoid use is an independent risk factor for developing sarcopenia in patients with rheumatoid arthritis: from the CHIKARA study. Clin. Rheumatol. 39, 1757\u20131764. https:\/\/doi.org\/10.1007\/s10067-020-04929-4 (2020).","journal-title":"Clin. Rheumatol."},{"key":"88939_CR62","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10067-022-06454-y","volume":"42","author":"A Ben Tekaya","year":"2023","unstructured":"Ben Tekaya, A. et al. Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis. Clin. Rheumatol. 42, 979\u2013997. https:\/\/doi.org\/10.1007\/s10067-022-06454-y (2023).","journal-title":"Clin. Rheumatol."},{"key":"88939_CR63","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty, R. E. et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J. Rheumatol. 31, 390\u2013392 (2004).","journal-title":"J. Rheumatol."},{"key":"88939_CR64","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1136\/ard.2010.138461","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580\u20131588. https:\/\/doi.org\/10.1136\/ard.2010.138461 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/ard.2010.133645","volume":"70","author":"M Rudwaleit","year":"2011","unstructured":"Rudwaleit, M. et al. The assessment of SpondyloArthritis international society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann. Rheum. Dis. 70, 25\u201331. https:\/\/doi.org\/10.1136\/ard.2010.133645 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR66","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/jcsm.12112","volume":"7","author":"DP Leong","year":"2016","unstructured":"Leong, D. P. et al. Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study. J. Cachexia Sarcopenia Muscle 7, 535\u2013546. https:\/\/doi.org\/10.1002\/jcsm.12112 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00421-006-0351-1","volume":"99","author":"D Leyk","year":"2007","unstructured":"Leyk, D. et al. Hand-grip strength of young men, women and highly trained female athletes. Eur. J. Appl. Physiol. 99, 415\u2013421. https:\/\/doi.org\/10.1007\/s00421-006-0351-1 (2007).","journal-title":"Eur. J. Appl. Physiol."},{"key":"88939_CR68","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.clnu.2017.03.018","volume":"37","author":"J Lopes","year":"2018","unstructured":"Lopes, J. et al. Reference equations for handgrip strength: Normative values in young adult and middle-aged subjects. Clin. Nutr. 37, 914\u2013918. https:\/\/doi.org\/10.1016\/j.clnu.2017.03.018 (2018).","journal-title":"Clin. Nutr."},{"key":"88939_CR69","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.clnu.2019.04.012","volume":"38","author":"CE Orsso","year":"2019","unstructured":"Orsso, C. E. et al. Low muscle mass and strength in pediatrics patients: Why should we care?. Clin. Nutr. 38, 2002\u20132015. https:\/\/doi.org\/10.1016\/j.clnu.2019.04.012 (2019).","journal-title":"Clin. Nutr."},{"key":"88939_CR70","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.amepre.2015.09.019","volume":"50","author":"MD Peterson","year":"2016","unstructured":"Peterson, M. D., Zhang, P., Saltarelli, W. A., Visich, P. S. & Gordon, P. M. Low muscle strength thresholds for the detection of cardiometabolic risk in adolescents. Am. J. Prev. Med. 50, 593\u2013599. https:\/\/doi.org\/10.1016\/j.amepre.2015.09.019 (2016).","journal-title":"Am. J. Prev. Med."},{"key":"88939_CR71","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/jcsm.12444","volume":"10","author":"MA Perez-Sousa","year":"2019","unstructured":"Perez-Sousa, M. A. et al. Gait speed as a mediator of the effect of sarcopenia on dependency in activities of daily living. J. Cachexia Sarcopenia Muscle 10, 1009\u20131015. https:\/\/doi.org\/10.1002\/jcsm.12444 (2019).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"88939_CR72","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/gerona\/glu012","volume":"69","author":"RR McLean","year":"2014","unstructured":"McLean, R. R. et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J. Gerontol. A Biol. Sci. Med. Sci. 69, 576\u2013583. https:\/\/doi.org\/10.1093\/gerona\/glu012 (2014).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"88939_CR73","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/jbmr.2492","volume":"30","author":"RR McLean","year":"2015","unstructured":"McLean, R. R. & Kiel, D. P. Developing consensus criteria for sarcopenia: an update. J. Bone Miner. Res. 30, 588\u2013592. https:\/\/doi.org\/10.1002\/jbmr.2492 (2015).","journal-title":"J. Bone Miner. Res."},{"key":"88939_CR74","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41598-020-57828-8","volume":"10","author":"JY Kim","year":"2020","unstructured":"Kim, J. Y., Oh, S., Park, H. Y., Jun, J. H. & Kim, H. J. Author correction: Comparisons of different indices of low muscle mass in relationship with cardiometabolic disorder. Sci. Rep. 10, 750. https:\/\/doi.org\/10.1038\/s41598-020-57828-8 (2020).","journal-title":"Sci. Rep."},{"key":"88939_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/annrheumdis-2017-212104","volume":"77","author":"JF Swart","year":"2018","unstructured":"Swart, J. F., van Dijkhuizen, E. H. P., Wulffraat, N. M. & de Roock, S. Clinical juvenile arthritis disease activity score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis. Ann. Rheum. Dis. 77, 336\u2013342. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212104 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR76","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/rheumatology\/ket150","volume":"52","author":"F McErlane","year":"2013","unstructured":"McErlane, F., Beresford, M. W., Baildam, E. M., Thomson, W. & Hyrich, K. L. Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis. Rheumatology (Oxford) 52, 1941\u20131951. https:\/\/doi.org\/10.1093\/rheumatology\/ket150 (2013).","journal-title":"Rheumatology (Oxford)"},{"key":"88939_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/apr.031720141923","volume":"3","author":"A Ravelli","year":"2014","unstructured":"Ravelli, A. The JADAS: a simple and reliable tool for the measurement of disease activity in juvenile idiopathic arthritis. Ann. Paediatr. Rheumatol. 3, 1\u20133. https:\/\/doi.org\/10.5455\/apr.031720141923 (2014).","journal-title":"Ann. Paediatr. Rheumatol."},{"key":"88939_CR78","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/ard.2008.094870","volume":"68","author":"C Lukas","year":"2009","unstructured":"Lukas, C. et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann. Rheum. Dis. 68, 18\u201324. https:\/\/doi.org\/10.1136\/ard.2008.094870 (2009).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1136\/ard.2010.138594","volume":"70","author":"P Machado","year":"2011","unstructured":"Machado, P. et al. Ankylosing spondylitis disease activity score (ASDAS): defining cut-off values for disease activity states and improvement scores. Ann. Rheum. Dis. 70, 47\u201353. https:\/\/doi.org\/10.1136\/ard.2010.138594 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"88939_CR80","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett, S. et al. A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index. J. Rheumatol. 21, 2286\u20132291 (1994).","journal-title":"J. Rheumatol."},{"key":"88939_CR81","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.1780380106","volume":"38","author":"JS Smolen","year":"1995","unstructured":"Smolen, J. S. et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthr. Rheum. 38, 38\u201343. https:\/\/doi.org\/10.1002\/art.1780380106 (1995).","journal-title":"Arthr. Rheum."},{"key":"88939_CR82","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/1756-185X.13460","volume":"22","author":"J Douglas-Withers","year":"2019","unstructured":"Douglas-Withers, J. et al. Associations between health assessment questionnaire disability index and physical performance in rheumatoid arthritis and osteoarthritis. Int. J. Rheum. Dis. 22, 417\u2013424. https:\/\/doi.org\/10.1111\/1756-185X.13460 (2019).","journal-title":"Int. J. Rheum. Dis."},{"key":"88939_CR83","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/key240","volume":"58","author":"S Norton","year":"2019","unstructured":"Norton, S. et al. Validation of the musculoskeletal health questionnaire in inflammatory arthritis: a psychometric evaluation. Rheumatology (Oxford) 58, 45\u201351. https:\/\/doi.org\/10.1093\/rheumatology\/key240 (2019).","journal-title":"Rheumatology (Oxford)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88939-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88939-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T23:31:55Z","timestamp":1741649515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88939-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88939"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88939-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study complied with the ethical principles of the Declaration of Helsinki. Written informed consent was obtained from all study participants. Ethical permission for the present investigation was obtained from the Regional Ethics Board in Kyiv, Ukraine (approval \u2116219, dated 04.11.2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}],"article-number":"8236"}}